Search research articles
Contact Us
Filters
Showing results (21-30 of 59) with videos related to
Page
of 6
Sort By:
Polish Journal of Pharmacology
|
November 3, 2004
Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe
Basem M William, Ahmed M Abdel-tawab, Essam A Hassan, et al.
Revista Brasileira De Hematologia E Hemoterapia
|
July 18, 2014
Transmission of lupus anticoagulant by allogeneic stem cell transplantation
Mira Romany Massoud, Basem M William, Katrina Harrill, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 14, 2025
Narrowing of the Racial Disparities Gap in Survival of Patients With Mycosis Fungoides: A Longitudinal Analysis of the SEER Database
Britney Le, Noha Soror, Hamid D Ismail, et al.
Hematology (Amsterdam, Netherlands)
|
July 16, 2015
Fasudil, a clinically safe ROCK inhibitor, decreases disease burden in a Cbl/Cbl-b deficiency-driven murine model of myeloproliferative disorders
Basem M William, Wei An, Dan Feng, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 19, 2013
Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation for Hodgkin lymphoma
Basem M William, Fausto R Loberiza, Victoria Whalen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 18, 2014
Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma
Basem M William, Mary S Allen, Fausto R Loberiza, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 2, 2015
Trends and Disparities in Cardiovascular Mortality Among Survivors of Hodgkin Lymphoma
Sadeer G Al-Kindi, Ghaith F Abu-Zeinah, Chang H Kim, et al.
Cancer Management and Research
|
December 8, 2021
Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience
Andrew Schaefer, Ying Huang, Adam Kittai, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 23, 2020
A Phase II Study of Midostaurin and 5-Azacitidine for Untreated Elderly and Unfit Patients With FLT3 Wild-type Acute Myelogenous Leukemia
Benjamin K Tomlinson, Molly M Gallogly, Donna M Kane, et al.
Oncotarget
|
November 8, 2017
Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignancies
Paolo F Caimi, Brenda W Cooper, Basem M William, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 59) with videos related to
Sort By:
Page
of 6
Polish Journal of Pharmacology
|
November 3, 2004
Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe
Basem M William, Ahmed M Abdel-tawab, Essam A Hassan, et al.
Revista Brasileira De Hematologia E Hemoterapia
|
July 18, 2014
Transmission of lupus anticoagulant by allogeneic stem cell transplantation
Mira Romany Massoud, Basem M William, Katrina Harrill, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 14, 2025
Narrowing of the Racial Disparities Gap in Survival of Patients With Mycosis Fungoides: A Longitudinal Analysis of the SEER Database
Britney Le, Noha Soror, Hamid D Ismail, et al.
Hematology (Amsterdam, Netherlands)
|
July 16, 2015
Fasudil, a clinically safe ROCK inhibitor, decreases disease burden in a Cbl/Cbl-b deficiency-driven murine model of myeloproliferative disorders
Basem M William, Wei An, Dan Feng, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 19, 2013
Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation for Hodgkin lymphoma
Basem M William, Fausto R Loberiza, Victoria Whalen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 18, 2014
Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma
Basem M William, Mary S Allen, Fausto R Loberiza, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 2, 2015
Trends and Disparities in Cardiovascular Mortality Among Survivors of Hodgkin Lymphoma
Sadeer G Al-Kindi, Ghaith F Abu-Zeinah, Chang H Kim, et al.
Cancer Management and Research
|
December 8, 2021
Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience
Andrew Schaefer, Ying Huang, Adam Kittai, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 23, 2020
A Phase II Study of Midostaurin and 5-Azacitidine for Untreated Elderly and Unfit Patients With FLT3 Wild-type Acute Myelogenous Leukemia
Benjamin K Tomlinson, Molly M Gallogly, Donna M Kane, et al.
Oncotarget
|
November 8, 2017
Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignancies
Paolo F Caimi, Brenda W Cooper, Basem M William, et al.
Page
of 6